Dawn T. Bravo

963 total citations
33 papers, 678 citations indexed

About

Dawn T. Bravo is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, Dawn T. Bravo has authored 33 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 7 papers in Surgery. Recurrent topics in Dawn T. Bravo's work include Neuropeptides and Animal Physiology (9 papers), Receptor Mechanisms and Signaling (6 papers) and Sinusitis and nasal conditions (6 papers). Dawn T. Bravo is often cited by papers focused on Neuropeptides and Animal Physiology (9 papers), Receptor Mechanisms and Signaling (6 papers) and Sinusitis and nasal conditions (6 papers). Dawn T. Bravo collaborates with scholars based in United States, France and Taiwan. Dawn T. Bravo's co-authors include James A. Waschek, Stanley M. Parsons, Mark L. Richards, David M. Jablons, Natalia G. Kolmakova, Jayakar V. Nayak, Liang You, Zhidong Xu, Peter H. Hwang and Kristopher Kuchenbecker and has published in prestigious journals such as Biochemistry, Biochemical and Biophysical Research Communications and Journal of Neurochemistry.

In The Last Decade

Dawn T. Bravo

33 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dawn T. Bravo United States 17 385 226 94 91 81 33 678
Phillip R. Purnell United States 14 580 1.5× 131 0.6× 272 2.9× 33 0.4× 24 0.3× 29 1.0k
Mei Xu China 12 440 1.1× 51 0.2× 71 0.8× 84 0.9× 134 1.7× 34 700
Zhijie Li China 19 750 1.9× 163 0.7× 175 1.9× 37 0.4× 75 0.9× 48 1.2k
Ying Xie China 18 878 2.3× 141 0.6× 187 2.0× 53 0.6× 61 0.8× 34 1.3k
Lesley Castillo Australia 14 402 1.0× 117 0.5× 208 2.2× 62 0.7× 48 0.6× 18 948
Ana Lúcia Abujamra Brazil 21 526 1.4× 133 0.6× 218 2.3× 43 0.5× 69 0.9× 39 968
Vincenzo Dattilo Italy 19 581 1.5× 50 0.2× 78 0.8× 59 0.6× 104 1.3× 36 889
Ingrid Langer Belgium 20 644 1.7× 553 2.4× 164 1.7× 75 0.8× 68 0.8× 53 987
Elżbieta Biesiada United States 10 364 0.9× 96 0.4× 40 0.4× 58 0.6× 31 0.4× 13 613

Countries citing papers authored by Dawn T. Bravo

Since Specialization
Citations

This map shows the geographic impact of Dawn T. Bravo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn T. Bravo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn T. Bravo more than expected).

Fields of papers citing papers by Dawn T. Bravo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn T. Bravo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn T. Bravo. The network helps show where Dawn T. Bravo may publish in the future.

Co-authorship network of co-authors of Dawn T. Bravo

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn T. Bravo. A scholar is included among the top collaborators of Dawn T. Bravo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn T. Bravo. Dawn T. Bravo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Zhenxiao, Nathalia Velasquez, Ting Ye, et al.. (2019). Topical Corticosteroid Pretreatment Mitigates Cellular Damage After Caustic Injury to the Nasal Upper Airway Epithelium. American Journal of Rhinology and Allergy. 33(3). 277–285. 2 indexed citations
2.
Edward, Justin A., Mrinmoy Sanyal, Wei Le, et al.. (2017). Selective expansion of human regulatory T cells in nasal polyps, and not adjacent tissue microenvironments, in individual patients exposed to steroids. Clinical Immunology. 179. 66–76. 10 indexed citations
3.
Bravo, Dawn T., Ethan Soudry, Justin A. Edward, et al.. (2013). Characterization of human upper airway epithelial progenitors. International Forum of Allergy & Rhinology. 3(10). 841–847. 8 indexed citations
4.
Patel, Zara M., et al.. (2012). Low‐frequency pulsed ultrasound in the nasal cavity and paranasal sinuses: a feasibility and distribution study. International Forum of Allergy & Rhinology. 2(4). 303–308. 6 indexed citations
5.
Hung, Ming‐Szu, Jian‐Hua Mao, Zhidong Xu, et al.. (2009). Cul4A is an oncogene in malignant pleural mesothelioma. Journal of Cellular and Molecular Medicine. 15(2). 350–358. 58 indexed citations
6.
Okamoto, Junichi, Iwao Mikami, Yuichi Tominaga, et al.. (2008). Inhibition of Hsp90 Leads to Cell Cycle Arrest and Apoptosis in Human Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 3(10). 1089–1095. 46 indexed citations
7.
Shi, Yihui, Biao He, Kristopher Kuchenbecker, et al.. (2007). Inhibition of Wnt‐2 and galectin‐3 synergistically destabilizes β‐catenin and induces apoptosis in human colorectal cancer cells. International Journal of Cancer. 121(6). 1175–1181. 49 indexed citations
8.
Bravo, Dawn T., Natalia G. Kolmakova, & Stanley M. Parsons. (2005). New transport assay demonstrates vesicular acetylcholine transporter has many alternative substrates. Neurochemistry International. 47(4). 243–247. 16 indexed citations
9.
Bravo, Dawn T., Douglas W. Harris, & Stanley M. Parsons. (2004). Reliable, Sensitive, Rapid and Quantitative Enzyme-Based Assay for Gamma-Hydroxybutyric Acid (GHB). Journal of Forensic Sciences. 49(2). 1–9. 24 indexed citations
10.
Bravo, Dawn T., Natalia G. Kolmakova, & Stanley M. Parsons. (2004). Transmembrane Reorientation of the Substrate-Binding Site in Vesicular Acetylcholine Transporter. Biochemistry. 43(27). 8787–8793. 9 indexed citations
11.
Bravo, Dawn T., et al.. (2003). Equilibrium Binding and Transport Studies. Humana Press eBooks. 227. 155–178. 5 indexed citations
12.
13.
Keller, James E., Dawn T. Bravo, & Stanley M. Parsons. (2000). Modification of Cysteines Reveals Linkage to Acetylcholine and Vesamicol Binding Sites in the Vesicular Acetylcholine Transporter of Torpedocalifornica. Journal of Neurochemistry. 74(4). 1739–1748. 8 indexed citations
14.
Waschek, James A., et al.. (1999). Targeting of Embryonic and Postnatal Autonomic and Enteric Neurons with a Vasoactive Intestinal Peptide Transgene. Journal of Neurochemistry. 73(4). 1739–1748. 6 indexed citations
15.
Waschek, James A., et al.. (1997). Retinoic Acid Regulation of the VIP and PACAP Autocrine Ligand and Receptor System in Human Neuroblastoma Cell Lines 1 and 2. Peptides. 18(6). 835–841. 25 indexed citations
16.
Waschek, James A., Julie A. Ellison, Dawn T. Bravo, & Vance Handley. (1996). Embryonic Expression of Vasoactive Intestinal Peptide (VIP) and VIP Receptor Genes. Journal of Neurochemistry. 66(4). 1762–1765. 48 indexed citations
17.
Waschek, James A., Mark L. Richards, & Dawn T. Bravo. (1995). Differential expression of VIP/PACAP receptor genes in breast, intestinal, and pancreatic cell lines. Cancer Letters. 92(2). 143–149. 50 indexed citations
18.
Waschek, James A., Dawn T. Bravo, & Mark L. Richards. (1995). High levels of vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor mRNA expression in primary and tumor lymphoid cells. Regulatory Peptides. 60(2-3). 149–157. 22 indexed citations
19.
Bravo, Dawn T., et al.. (1994). High conservation of upstream regulatory sequences on the human and mouse vasoactive intestinal peptide (VIP) genes. DNA sequence. 5(1). 25–29. 16 indexed citations
20.
Ágoston, Dénes V., Dawn T. Bravo, & James A. Waschek. (1990). Expression of a chimeric VIP gene is targeted to the intestine in transgenic mice. Journal of Neuroscience Research. 27(4). 479–486. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Phillip R. Purnell Breakdown of academic impact, for papers by Mei Xu Breakdown of academic impact, for papers by Zhijie Li Breakdown of academic impact, for papers by Ying Xie Breakdown of academic impact, for papers by Lesley Castillo Breakdown of academic impact, for papers by Ana Lúcia Abujamra Breakdown of academic impact, for papers by Vincenzo Dattilo Breakdown of academic impact, for papers by Ingrid Langer Breakdown of academic impact, for papers by Elżbieta Biesiada
Rankless by CCL
2026